102 related articles for article (PubMed ID: 29748132)
1. Assessment of cytosolic free calcium changes during ceramide-induced cell death in MDA-MB-231 breast cancer cells expressing the calcium sensor GCaMP6m.
Bassett JJ; Bong AHL; Janke EK; Robitaille M; Roberts-Thomson SJ; Peters AA; Monteith GR
Cell Calcium; 2018 Jun; 72():39-50. PubMed ID: 29748132
[TBL] [Abstract][Full Text] [Related]
2. NCS-1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin.
Bong AHL; Robitaille M; Milevskiy MJG; Roberts-Thomson SJ; Monteith GR
Mol Oncol; 2020 Jan; 14(1):87-104. PubMed ID: 31647602
[TBL] [Abstract][Full Text] [Related]
3. Assessment of doxorubicin-induced remodeling of Ca
Bong AHL; Bassett JJ; Roberts-Thomson SJ; Monteith GR
Biochem Biophys Res Commun; 2020 Feb; 522(2):532-538. PubMed ID: 31780263
[TBL] [Abstract][Full Text] [Related]
4. C
Chang WT; Wu CY; Lin YC; Wu MT; Su KL; Yuan SS; Wang HD; Fong Y; Lin YH; Chiu CC
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480728
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation.
Azimi I; Bong AH; Poo GXH; Armitage K; Lok D; Roberts-Thomson SJ; Monteith GR
Cell Mol Life Sci; 2018 Dec; 75(24):4525-4537. PubMed ID: 30105615
[TBL] [Abstract][Full Text] [Related]
6. The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Peters AA; Milevskiy MJ; Lee WC; Curry MC; Smart CE; Saunus JM; Reid L; da Silva L; Marcial DL; Dray E; Brown MA; Lakhani SR; Roberts-Thomson SJ; Monteith GR
Sci Rep; 2016 May; 6():25505. PubMed ID: 27148852
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells.
Curry MC; Peters AA; Kenny PA; Roberts-Thomson SJ; Monteith GR
Biochem Biophys Res Commun; 2013 May; 434(3):695-700. PubMed ID: 23602897
[TBL] [Abstract][Full Text] [Related]
8. Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.
Curry MC; Luk NA; Kenny PA; Roberts-Thomson SJ; Monteith GR
J Biol Chem; 2012 Aug; 287(34):28598-608. PubMed ID: 22733819
[TBL] [Abstract][Full Text] [Related]
9. Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
Chovancova B; Liskova V; Miklikova S; Hudecova S; Babula P; Penesova A; Sevcikova A; Durinikova E; Novakova M; Matuskova M; Krizanova O
Biochem Pharmacol; 2020 Jan; 171():113695. PubMed ID: 31706846
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
11. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
12. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.
Bolanz KA; Kovacs GG; Landowski CP; Hediger MA
Mol Cancer Res; 2009 Dec; 7(12):2000-10. PubMed ID: 19996302
[TBL] [Abstract][Full Text] [Related]
14. Increased matrix stiffness suppresses ATP-induced sustained Ca
So CL; Meinert C; Xia Q; Robitaille M; Roberts-Thomson SJ; Monteith GR
Cell Calcium; 2022 Jun; 104():102569. PubMed ID: 35248793
[TBL] [Abstract][Full Text] [Related]
15. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
Moon D; McCormack D; McDonald D; McFadden D
J Surg Res; 2013 Apr; 180(2):208-15. PubMed ID: 22572619
[TBL] [Abstract][Full Text] [Related]
18. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
19. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry.
Hammadi M; Chopin V; Matifat F; Dhennin-Duthille I; Chasseraud M; Sevestre H; Ouadid-Ahidouch H
J Cell Physiol; 2012 Dec; 227(12):3837-46. PubMed ID: 22495877
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
